1
|
Fordice J, Kershaw C, El-Naggar A and
Goepfert H: Adenoid cystic carcinoma of the head and neck:
predictors of morbidity and mortality. Arch Otolaryngol Head Neck
Surg. 125:149–152. 1999. View Article : Google Scholar : PubMed/NCBI
|
2
|
Terhaard CH, Lubsen H, Van der Tweel I, et
al: Salivary gland carcinoma: independent prognostic factors for
locoregional control, distant metastases and overall survival:
results of the Dutch head and neck oncology cooperative group. Head
Neck. 26:681–693. 2004. View Article : Google Scholar
|
3
|
Polat B, Fassnacht M, Pfreundner L, et al:
Radiotherapy in adrenocortical carcinoma. Cancer. 115:2816–2823.
2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Karin M and Ben-Neriah Y: Phosphorylation
meets ubiquitination:the control of NF-kappa B activity. Annu Rev
Immunol. 18:621–663. 2000. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ghosh S, May MJ and Kopp EB: NF-kappa B
and Rel proteins: evolutionarily conserved mediators of immune
responses. Annu Rev Immunol. 16:225–260. 1998. View Article : Google Scholar : PubMed/NCBI
|
6
|
Pajonk F, Pajonk K and McBride WH:
Inhibition of NF-κB, clonogenicity, and radiosensitivity of human
cancer cells. J Natl Cancer Inst. 91:1956–1960. 1999.
|
7
|
Greten FR and Karin M: The IKK/NF-κB
activation pathway-A target for prevention and treatment of cancer.
Cancer Lett. 206:193–199. 2003.
|
8
|
Pahl HL: Activators and target genes of
Rel/NF-κB transcription factors. Oncogene. 18:6853–6866. 1999.
|
9
|
Schwartz SA, Hernandez A and Mark Evers B:
The role of NF-kappaB/IkappaB proteins in cancer: implications for
novel treatment strategies. Surg Oncol. 8:143–153. 1999. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sandur SK, Deorukhkar A, Pandey MK, et al:
Curcumin modulates the radiosensitivity of colorectal cancer cells
by suppressing constitutive and inducible NF-κB activity. Int J
Radiat Oncol Biol Phys. 75:534–542. 2009.PubMed/NCBI
|
11
|
Jung M, Zhang Y, Lee S and Dritschilo A:
Correction of radiation sensitivity in ataxia telangiectasia cells
by truncated IκB-α. Science. 268:1619–1621. 1995.
|
12
|
Brown K, Gerstberger S, Carlson L,
Franzoso G and Siebenlist U: Control of IκB-α proteolysis by
site-specific signal induced phosphorylation. Science.
267:1485–1488. 1995.
|
13
|
Cataldi A, Zauli G, Di Pietro R, Castorina
S and Rana R: Involvement of the pathway
phosphatidylinositol-3-kinase/AKT-1 in the establishment of the
survival response to ionizing radiation. Cell Signal. 13:369–375.
2001. View Article : Google Scholar : PubMed/NCBI
|
14
|
Weichselbaum RR, Hallahan D, Fuks Z and
Kufe D: Radiation induction of immediate early genes: effectors of
the radiation-stress response. Int J Radiat Oncol Biol Phys.
30:229–234. 1994. View Article : Google Scholar : PubMed/NCBI
|
15
|
Magné N, Toillon RA, Bottero V, et al:
NF-κB modulation and ionizing radiation: mechanisms and future
directions for cancer treatment. Cancer Lett. 231:158–168.
2006.
|
16
|
Tergaonkar V, Bottero V, Ikawa M, Li Q and
Verma IM: IκB kinase-independent IκBα degradation pathway:
functional NF-κB activity and implications for cancer therapy. Mol
Cell Biol. 23:8070–8083. 2003.
|
17
|
Fujioka S, Sclabas GM, Schmidt C, et al:
Inhibition of constitutive NF-κB activity by IκBαM suppresses
tumorigenesis. Oncogene. 22:1365–1370. 2003.
|
18
|
Darnell JE Jr: Transcription factors as
targets for cancer therapy. Nat Rev Cancer. 2:740–749. 2002.
View Article : Google Scholar : PubMed/NCBI
|
19
|
van Hogerlinden M, Rozell BL,
Ahrlund-Richter L and Toftgård R: Squamous cell carcinomas and
increased apoptosis in skin with inhibited Rel/nuclear
factor-kappaB signaling. Cancer Res. 59:3299–3303. 1999.PubMed/NCBI
|
20
|
Duffey DC, Crowl-Bancroft CV, Chen Z, et
al: Inhibition of transcription factor nuclear factor-kappa B by a
mutant inhibitor-kappa Balpha attenuates resistance of human head
and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell
death. Br J Cancer. 83:1367–1374. 2000. View Article : Google Scholar
|
21
|
Li C, Yang Z, Zhai C, et al: Maslinic acid
potentiates the anti-tumor activity of tumor necrosis factor alpha
by inhibiting NF-kappaB signaling pathway. Mol Cancer. 9:732010.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Baud V and Karin M: Is NF-kappaB a good
target for cancer therapy? Hopes and pitfalls Nat Rev Drug Discov.
8:33–40. 2009. View
Article : Google Scholar : PubMed/NCBI
|
23
|
Zhang J, Peng B and Chen X: Expressions of
nuclear factor kappaB, inducible nitric oxide synthase, and
vascular endothelial growth factor in adenoid cystic carcinoma of
salivary glands: correlations with the angiogenesis and clinical
outcome. Clin Cancer Res. 11:7334–7343. 2005. View Article : Google Scholar
|
24
|
Magné N, Toillon RA, Bottero V, et al:
NF-nB modulation and ionizing radiation: mechanisms and future
directions for cancer treatment. Cancer Lett. 231:158–168.
2006.PubMed/NCBI
|
25
|
Courtois G and Gilmore TD: Mutations in
the NF-κB signaling pathway: implications for human disease.
Oncogene. 25:6831–6843. 2006.
|